NeuroHelp
PrivateLast Round
Seed
Nov 1, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroHelp operates in Healthcare & Life Sciences and is based in Ramat Gan. Its latest recorded funding round was a Seed round in November 2022.
NeuroHelp is a health tech company that develops home-use wearable EEG monitoring systems and AI-powered software for seizure detection and prediction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroHelp Comparables
Compare NeuroHelp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quadlytics Inc. | 85% |
For institutional investors. Book with your work email.
NeuroHelp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2022 | ||||
| Accelerator | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroHelp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| eHealth Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 255% MoM, reaching 468.
- May 1, 2025
Monthly visitors increased 79% MoM.
For institutional investors. Book with your work email.
NeuroHelp Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroHelp's valuation, stock price, and market status.
Is NeuroHelp a public or private company?
NeuroHelp is a private company.
What is the current stock price of NeuroHelp?
NeuroHelp is a private company, so its shares have no public market price. Caplight tracks NeuroHelp's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroHelp worth (valuation)?
Valuation information for NeuroHelp is not publicly available.
Can I buy NeuroHelp stock?
NeuroHelp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroHelp's last funding round?
NeuroHelp's most recent funding round was Seed on November 1, 2022.
Who are the main investors in NeuroHelp?
Key investors in NeuroHelp include Israel Innovation Authority, eHealth Ventures.
Will NeuroHelp IPO soon?
No public IPO plans have been announced for NeuroHelp.
How can I track NeuroHelp secondary market activity?
Caplight tracks bids, offers, and trades in NeuroHelp's shares on secondary markets.